Annual Meeting Recordings are now available for purchase
296510
Better breast cancer care among extremely poor women in Canada than in the United States: Historical cohort support of a health insurance explanation
Tuesday, November 18, 2014
: 12:30 PM - 12:50 PM
Kevin M. Gorey
,
School of Social Work, University of Windsor, Windsor, ON, Canada
Nancy L. Richter
,
School of Social Work, University of Windsor, Windsor, ON, Canada
Isaac N. Luginaah
,
Department of Geography, University of Western Ontario, London, ON, Canada
Caroline Hamm
,
Schulich School of Medicine and Dentistry, University of Western Ontario and Windsor Regional Cancer Center, London, ON, Canada
Eric J. Holowaty
,
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
GuangYong Zou
,
Department of Epidemiology and Biostatistics, University of Western Ontario and Robarts Research Institute, London, ON, Canada
Madhan K. Balagurusamy
,
School of Social Work, University of Windsor, Windsor, ON, Canada
The most substantial reform of American health care since the 1960’s Great Society reforms, the Affordable Care Act (ACA), became law in the midst of the Great Recession. Advocates of Canada-like, single-payer reforms wondered about the act’s ultimate effects as it leaves the present multi-tiered health care system in the US essentially intact. This historical study estimated the protective effects of a universally accessible, single-payer health care system versus a multi-payer system that leaves many uninsured or underinsured by comparing breast cancer care among extremely poor women in Ontario and California between 1996 and 2011. The Canadian women were consistently advantaged particularly as compared to inadequately insured American women. They were diagnosed earlier (standardized rate ratio [RR] = 1.12) and enjoyed better access to breast conserving surgery (RR = 1.48) as well as radiation (RR = 1.60) and hormone therapies (RR = 1.78). The Canadian women even experienced shorter waits for surgery (RR = 0.58) and radiation therapy (RR = 0.44). Consequently, the Canadian women were much more likely to survive longer. Regression analyses indicated that health insurance explained most of the Canadian advantages. Over this study’s 15-year timeframe 31,500 late diagnoses, 94,500 sub-optimum treatment plans and 103,500 early deaths were estimated among poor American women due to the relative inadequacy of their health insurance coverage. The ACA will probably reduce such inequities by half, while single-payer reform would probably completely eliminate them. Making high quality health care available to all Americans seems a necessary step toward a just society.
Learning Areas:
Advocacy for health and health education
Chronic disease management and prevention
Epidemiology
Provision of health care to the public
Public health or related public policy
Social and behavioral sciences
Learning Objectives:
Describe the strong associations of extreme poverty with breast cancer treatment inaccessibility and very low survival rates in the United States.
Describe the large surgical and adjuvant therapy access and survival advantages experienced by extremely poor Canadian women with breast cancer.
Discuss the much more equitable breast cancer care observed in Canada in light of its most probable explanation--Canada's single payer, universally accessible health care system.
Discuss implications for contemporary and future reforms of health care in the United States.
Keyword(s): Health Care Access, Affordable Care Act
Presenting author's disclosure statement:Qualified on the content I am responsible for because: Qualified on the content I am responsible for because: I am a federally funded epidemiologist with 20 years of research experience in social epidemiology and international comparative health services research the results of which have been published in 102 peer-reviewed scientific journal articles.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.